Market revenue in 2023 | USD 53,793.5 million |
Market revenue in 2030 | USD 99,100.7 million |
Growth rate | 9.1% (CAGR from 2023 to 2030) |
Largest segment | Contract manufacturing |
Fastest growing segment | Contract Development |
Historical data covered | 2018 - 2022 |
Base year for estimation | 2023 |
Forecast period covered | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Contract Development, Contract Manufacturing |
Key market players worldwide | Catalent Inc, Lonza Group Ltd, Recipharm, Siegfried Holding AG, Thermo Fisher Scientific Inc, Labcorp Drug Development, Jabil Inc, Syngene, IQVIA Holdings Inc, Almac Group, Ajinomoto Co Inc, Alcami, Vetter Pharma-Fertigung |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to healthcare contract development and manufacturing organization market will help companies and investors design strategic landscapes.
Contract manufacturing was the largest segment with a revenue share of 82.23% in 2023. Horizon Databook has segmented the Europe healthcare contract development and manufacturing organization market based on contract development, contract manufacturing covering the revenue growth of each sub-segment from 2018 to 2030.
Europe’s healthcare contract development & manufacturing organization market held the third-largest share of 21.8% in 2020. It is one of the leading regions with advanced technologies and well-established infrastructure, resulting in improved healthcare facilities & patient care.
Players seeking entry in the European market require extensive knowledge of different regulatory procedures and services in various member states of the EU. Small and midsized medical device companies without a regulatory affairs department usually hire a regulatory consultant or a legal representative to assist them through various stages of regulatory approval processes needed for commercializing their products in Europe.
Regulatory framework in the EU is expected to be subjected to major changes, which may affect market access or entry. The market is expected to grow lucratively in this region due to stringent regulatory policies. In addition, the EU MDR, which came into effect in May 2017, has made it mandatory for manufacturers to monitor the quality, performance, and quality of their medical devices.
Horizon Databook provides a detailed overview of continent-level data and insights on the Europe healthcare contract development and manufacturing organization market , including forecasts for subscribers. This continent databook contains high-level insights into Europe healthcare contract development and manufacturing organization market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account